Dengue  ||| S:0 E:7 ||| JJ
pathogenesis ||| S:7 E:19 ||| NN
:  ||| S:19 E:21 ||| :
a  ||| S:21 E:23 ||| DT
disease  ||| S:23 E:31 ||| NN
driven  ||| S:31 E:38 ||| VBN
by  ||| S:38 E:41 ||| IN
the  ||| S:41 E:45 ||| DT
host  ||| S:45 E:50 ||| NN
response  ||| S:50 E:59 ||| NN
Dengue  ||| S:59 E:66 ||| NNP
viruses  ||| S:66 E:74 ||| NNS
cause  ||| S:74 E:80 ||| VBP
mild  ||| S:80 E:85 ||| JJ
disease  ||| S:85 E:93 ||| NN
in  ||| S:93 E:96 ||| IN
the  ||| S:96 E:100 ||| DT
majority  ||| S:100 E:109 ||| NN
of  ||| S:109 E:112 ||| IN
infected  ||| S:112 E:121 ||| JJ
individuals ||| S:121 E:132 ||| NNS
.  ||| S:132 E:134 ||| .
In  ||| S:134 E:137 ||| IN
most  ||| S:137 E:142 ||| JJS
cases ||| S:142 E:147 ||| NNS
,  ||| S:147 E:149 ||| ,
the  ||| S:149 E:153 ||| DT
disease  ||| S:153 E:161 ||| NN
is  ||| S:161 E:164 ||| VBZ
characterised  ||| S:164 E:178 ||| VBN
by  ||| S:178 E:181 ||| IN
fever ||| S:181 E:186 ||| NN
,  ||| S:186 E:188 ||| ,
headache ||| S:188 E:196 ||| NN
,  ||| S:196 E:198 ||| ,
pain  ||| S:198 E:203 ||| NN
behind  ||| S:203 E:210 ||| IN
the  ||| S:210 E:214 ||| DT
eyes ||| S:214 E:218 ||| NNS
,  ||| S:218 E:220 ||| ,
muscle  ||| S:220 E:227 ||| NN
ache ||| S:227 E:231 ||| NN
,  ||| S:231 E:233 ||| ,
joint  ||| S:233 E:239 ||| JJ
pains ||| S:239 E:244 ||| NNS
,  ||| S:244 E:246 ||| ,
vomiting  ||| S:246 E:255 ||| VBG
and  ||| S:255 E:259 ||| CC
diarrhoea ||| S:259 E:268 ||| NN
.  ||| S:268 E:270 ||| .
In  ||| S:270 E:273 ||| IN
a  ||| S:273 E:275 ||| DT
low  ||| S:275 E:279 ||| JJ
percentage  ||| S:279 E:290 ||| NN
of  ||| S:290 E:293 ||| IN
patients ||| S:293 E:301 ||| NNS
,  ||| S:301 E:303 ||| ,
bleeding  ||| S:303 E:312 ||| VBG
and  ||| S:312 E:316 ||| CC
loss  ||| S:316 E:321 ||| NN
of  ||| S:321 E:324 ||| IN
plasma  ||| S:324 E:331 ||| NNS
( ||| S:331 E:332 ||| -LRB-
haemorrhage  ||| S:332 E:344 ||| NN
and  ||| S:344 E:348 ||| CC
plasma  ||| S:348 E:355 ||| JJ
leakage ||| S:355 E:362 ||| NN
)  ||| S:362 E:364 ||| -RRB-
may  ||| S:364 E:368 ||| MD
occur ||| S:368 E:373 ||| VB
.  ||| S:373 E:375 ||| .
The  ||| S:375 E:379 ||| DT
hyper-permeability  ||| S:379 E:398 ||| JJ
syndrome  ||| S:398 E:407 ||| NN
results  ||| S:407 E:415 ||| NNS
in  ||| S:415 E:418 ||| IN
plasma  ||| S:418 E:425 ||| JJ
leakage  ||| S:425 E:433 ||| NN
and ||| S:433 E:436 ||| CC
,  ||| S:436 E:438 ||| ,
if  ||| S:438 E:441 ||| IN
the  ||| S:441 E:445 ||| DT
compensatory  ||| S:445 E:458 ||| JJ
mechanisms  ||| S:458 E:469 ||| NNS
of  ||| S:469 E:472 ||| IN
the  ||| S:472 E:476 ||| DT
body  ||| S:476 E:481 ||| NN
fail  ||| S:481 E:486 ||| VBP
to  ||| S:486 E:489 ||| TO
control  ||| S:489 E:497 ||| VB
the  ||| S:497 E:501 ||| DT
plasma  ||| S:501 E:508 ||| JJ
leakage  ||| S:508 E:516 ||| NN
or  ||| S:516 E:519 ||| CC
if  ||| S:519 E:522 ||| IN
medical  ||| S:522 E:530 ||| JJ
intervention  ||| S:530 E:543 ||| NN
is  ||| S:543 E:546 ||| VBZ
late ||| S:546 E:550 ||| RB
,  ||| S:550 E:552 ||| ,
shock  ||| S:552 E:558 ||| NN
may  ||| S:558 E:562 ||| MD
set  ||| S:562 E:566 ||| VB
in ||| S:566 E:568 ||| RP
.  ||| S:568 E:570 ||| .
Profound  ||| S:570 E:579 ||| JJ
shock  ||| S:579 E:585 ||| NN
will  ||| S:585 E:590 ||| MD
subsequently  ||| S:590 E:603 ||| RB
lead  ||| S:603 E:608 ||| VB
to  ||| S:608 E:611 ||| TO
acidic  ||| S:611 E:618 ||| VB
blood  ||| S:618 E:624 ||| NN
( ||| S:624 E:625 ||| -LRB-
metabolic  ||| S:625 E:635 ||| FW
acidosis ||| S:635 E:643 ||| FW
)  ||| S:643 E:645 ||| -RRB-
and  ||| S:645 E:649 ||| CC
development  ||| S:649 E:661 ||| NN
of  ||| S:661 E:664 ||| IN
disseminated  ||| S:664 E:677 ||| FW
intravascular  ||| S:677 E:691 ||| FW
coagulation  ||| S:691 E:703 ||| FW
( ||| S:703 E:704 ||| -LRB-
DIC ||| S:704 E:707 ||| NNP
) ||| S:707 E:708 ||| -RRB-
.  ||| S:708 E:710 ||| .
During  ||| S:710 E:717 ||| IN
DIC  ||| S:717 E:721 ||| NNP
multiple  ||| S:721 E:730 ||| FW
micro  ||| S:730 E:736 ||| FW
thromboses  ||| S:736 E:747 ||| FW
occur ||| S:747 E:752 ||| FW
,  ||| S:752 E:754 ||| ,
leading  ||| S:754 E:762 ||| VBG
to  ||| S:762 E:765 ||| TO
organ  ||| S:765 E:771 ||| VB
failure ||| S:771 E:778 ||| NN
.  ||| S:778 E:780 ||| .
The  ||| S:780 E:784 ||| DT
mechanisms  ||| S:784 E:795 ||| NNS
governing  ||| S:795 E:805 ||| VBG
pathogenesis  ||| S:805 E:818 ||| NN
of  ||| S:818 E:821 ||| IN
these  ||| S:821 E:827 ||| DT
forms  ||| S:827 E:833 ||| NNS
of  ||| S:833 E:836 ||| IN
severe  ||| S:836 E:843 ||| JJ
disease  ||| S:843 E:851 ||| NN
are  ||| S:851 E:855 ||| VBP
not  ||| S:855 E:859 ||| RB
clear ||| S:859 E:864 ||| JJ
.  ||| S:864 E:866 ||| .
High  ||| S:866 E:871 ||| JJ
amounts  ||| S:871 E:879 ||| NNS
of  ||| S:879 E:882 ||| IN
virus  ||| S:882 E:888 ||| NN
in  ||| S:888 E:891 ||| IN
the  ||| S:891 E:895 ||| DT
blood  ||| S:895 E:901 ||| NN
are  ||| S:901 E:905 ||| VBP
believed  ||| S:905 E:914 ||| VBN
to  ||| S:914 E:917 ||| TO
cause  ||| S:917 E:923 ||| VB
vascular  ||| S:923 E:932 ||| JJ
fragility  ||| S:932 E:942 ||| NN
which ||| S:942 E:947 ||| WDT
,  ||| S:947 E:949 ||| ,
together  ||| S:949 E:958 ||| RB
with  ||| S:958 E:963 ||| IN
infection  ||| S:963 E:973 ||| NN
of  ||| S:973 E:976 ||| IN
endothelial  ||| S:976 E:988 ||| JJ
cells  ||| S:988 E:994 ||| NNS
and  ||| S:994 E:998 ||| CC
high  ||| S:998 E:1003 ||| JJ
levels  ||| S:1003 E:1010 ||| NNS
of  ||| S:1010 E:1013 ||| IN
cytokines  ||| S:1013 E:1023 ||| NN
and  ||| S:1023 E:1027 ||| CC
other  ||| S:1027 E:1033 ||| JJ
soluble  ||| S:1033 E:1041 ||| JJ
mediators ||| S:1041 E:1050 ||| NNS
,  ||| S:1050 E:1052 ||| ,
may  ||| S:1052 E:1056 ||| MD
result  ||| S:1056 E:1063 ||| VB
in  ||| S:1063 E:1066 ||| IN
bleeding ||| S:1066 E:1074 ||| NN
.  ||| S:1074 E:1076 ||| .
In  ||| S:1076 E:1079 ||| IN
the  ||| S:1079 E:1083 ||| DT
absence  ||| S:1083 E:1091 ||| NN
of  ||| S:1091 E:1094 ||| IN
a  ||| S:1094 E:1096 ||| DT
correlation  ||| S:1096 E:1108 ||| NN
between  ||| S:1108 E:1116 ||| IN
the  ||| S:1116 E:1120 ||| DT
amount  ||| S:1120 E:1127 ||| NN
of  ||| S:1127 E:1130 ||| IN
virus  ||| S:1130 E:1136 ||| NN
in  ||| S:1136 E:1139 ||| IN
the  ||| S:1139 E:1143 ||| DT
blood  ||| S:1143 E:1149 ||| NN
and  ||| S:1149 E:1153 ||| CC
disease  ||| S:1153 E:1161 ||| NN
severity ||| S:1161 E:1169 ||| NN
,  ||| S:1169 E:1171 ||| ,
it  ||| S:1171 E:1174 ||| PRP
is  ||| S:1174 E:1177 ||| VBZ
likely  ||| S:1177 E:1184 ||| RB
that  ||| S:1184 E:1189 ||| IN
response  ||| S:1189 E:1198 ||| NN
to  ||| S:1198 E:1201 ||| TO
infection  ||| S:1201 E:1211 ||| NN
is  ||| S:1211 E:1214 ||| VBZ
an  ||| S:1214 E:1217 ||| DT
important  ||| S:1217 E:1227 ||| JJ
cause  ||| S:1227 E:1233 ||| NN
of  ||| S:1233 E:1236 ||| IN
disease ||| S:1236 E:1243 ||| NN
.  ||| S:1243 E:1245 ||| .
The  ||| S:1245 E:1249 ||| DT
aberrant  ||| S:1249 E:1258 ||| JJ
immune  ||| S:1258 E:1265 ||| JJ
response  ||| S:1265 E:1274 ||| NN
to  ||| S:1274 E:1277 ||| TO
infection  ||| S:1277 E:1287 ||| NN
is  ||| S:1287 E:1290 ||| VBZ
believed  ||| S:1290 E:1299 ||| VBN
to  ||| S:1299 E:1302 ||| TO
result  ||| S:1302 E:1309 ||| VB
in  ||| S:1309 E:1312 ||| IN
a  ||| S:1312 E:1314 ||| DT
cytokine  ||| S:1314 E:1323 ||| JJ
storm ||| S:1323 E:1328 ||| NN
,  ||| S:1328 E:1330 ||| ,
defined  ||| S:1330 E:1338 ||| VBN
as  ||| S:1338 E:1341 ||| IN
an  ||| S:1341 E:1344 ||| DT
imbalance  ||| S:1344 E:1354 ||| NN
between  ||| S:1354 E:1362 ||| IN
cytokines  ||| S:1362 E:1372 ||| NNS
driving  ||| S:1372 E:1380 ||| VBG
an  ||| S:1380 E:1383 ||| DT
inflammation  ||| S:1383 E:1396 ||| NN
( ||| S:1396 E:1397 ||| -LRB-
pro-inflammatory ||| S:1397 E:1413 ||| NNP
)  ||| S:1413 E:1415 ||| -RRB-
and  ||| S:1415 E:1419 ||| CC
those  ||| S:1419 E:1425 ||| DT
silencing  ||| S:1425 E:1435 ||| NN
an  ||| S:1435 E:1438 ||| DT
inflammation  ||| S:1438 E:1451 ||| NN
( ||| S:1451 E:1452 ||| -LRB-
anti-inflammatory ||| S:1452 E:1469 ||| NNP
) ||| S:1469 E:1470 ||| -RRB-
.  ||| S:1470 E:1472 ||| .
Several  ||| S:1472 E:1480 ||| JJ
lines  ||| S:1480 E:1486 ||| NNS
of  ||| S:1486 E:1489 ||| IN
evidence  ||| S:1489 E:1498 ||| NN
indicate  ||| S:1498 E:1507 ||| VBP
that  ||| S:1507 E:1512 ||| DT
displacement  ||| S:1512 E:1525 ||| NN
of  ||| S:1525 E:1528 ||| IN
viral  ||| S:1528 E:1534 ||| JJ
genotype  ||| S:1534 E:1543 ||| NN
and  ||| S:1543 E:1547 ||| CC
host  ||| S:1547 E:1552 ||| NN
genetic  ||| S:1552 E:1560 ||| JJ
background  ||| S:1560 E:1571 ||| NN
are  ||| S:1571 E:1575 ||| VBP
key  ||| S:1575 E:1579 ||| JJ
factors  ||| S:1579 E:1587 ||| NNS
driving  ||| S:1587 E:1595 ||| VBG
the  ||| S:1595 E:1599 ||| DT
production  ||| S:1599 E:1610 ||| NN
of  ||| S:1610 E:1613 ||| IN
a  ||| S:1613 E:1615 ||| DT
cytokine  ||| S:1615 E:1624 ||| JJ
storm ||| S:1624 E:1629 ||| NN
.  ||| S:1629 E:1631 ||| .
Several  ||| S:1631 E:1639 ||| JJ
cytokines  ||| S:1639 E:1649 ||| NNS
are  ||| S:1649 E:1653 ||| VBP
known  ||| S:1653 E:1659 ||| VBN
to  ||| S:1659 E:1662 ||| TO
induce  ||| S:1662 E:1669 ||| VB
apoptosis ||| S:1669 E:1678 ||| NNS
,  ||| S:1678 E:1680 ||| ,
a  ||| S:1680 E:1682 ||| DT
form  ||| S:1682 E:1687 ||| NN
of  ||| S:1687 E:1690 ||| IN
cell  ||| S:1690 E:1695 ||| NN
suicide  ||| S:1695 E:1703 ||| NN
( ||| S:1703 E:1704 ||| -LRB-
cause  ||| S:1704 E:1710 ||| NN
of  ||| S:1710 E:1713 ||| IN
haemorrhage ||| S:1713 E:1724 ||| CD
) ||| S:1724 E:1725 ||| -RRB-
,  ||| S:1725 E:1727 ||| ,
and ||| S:1727 E:1730 ||| CC
/ ||| S:1730 E:1731 ||| NNP
or  ||| S:1731 E:1734 ||| CC
affect  ||| S:1734 E:1741 ||| VB
adherens  ||| S:1741 E:1750 ||| JJ
junctions  ||| S:1750 E:1760 ||| NNS
( ||| S:1760 E:1761 ||| -LRB-
cause  ||| S:1761 E:1767 ||| NN
permeability ||| S:1767 E:1779 ||| NN
)  ||| S:1779 E:1781 ||| -RRB-
in  ||| S:1781 E:1784 ||| IN
vitro ||| S:1784 E:1789 ||| NN
.  ||| S:1789 E:1791 ||| .
Whether  ||| S:1791 E:1799 ||| IN
these  ||| S:1799 E:1805 ||| DT
cytokines  ||| S:1805 E:1815 ||| NN
may  ||| S:1815 E:1819 ||| MD
have  ||| S:1819 E:1824 ||| VB
such  ||| S:1824 E:1829 ||| JJ
effects  ||| S:1829 E:1837 ||| NNS
in  ||| S:1837 E:1840 ||| IN
vivo  ||| S:1840 E:1845 ||| NN
remains  ||| S:1845 E:1853 ||| VBZ
to  ||| S:1853 E:1856 ||| TO
be  ||| S:1856 E:1859 ||| VB
established ||| S:1859 E:1870 ||| VBN
.  ||| S:1870 E:1872 ||| .
